At 1115 hours, a combined 5.23 million shares representing 2.6% of the company's total equity, have changed hands against an average sub 1.5 million shares that were traded daily in the past two weeks on NSE and BSE.
In the past six trading sessions, the stock has rallied 20% from Rs 427 on April 9 on buzz of a bonus issue. The benchmark CNX Nifty has remained unchanged during the period.
However, the company has denied any possibilities of a bonus issue, saying, "At the outset would like to deny the news item."
Meanwhile, Biocon said that its board of directors is scheduled to meet on April 24 to announce the audited financial results for the year ended on March 31, 2014.
Earlier, in September 2008, the company had issued bonus shares in the ratio of 1:1.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
